Citation Impact
Citing Papers
Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3
2015 Standout
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Ischemia induces nuclear NOX2 expression in cardiomyocytes and subsequently activates apoptosis
2006
Ischemia‐reperfusion selectively impairs nitric oxide‐ mediated dilation in coronary arterioles: counteracting role of arginase
2003
Early changes in myocardial antioxidant enzymes in rats treated with adriamycin
2002
Production of Reactive Oxygen Species by Mitochondria
2003
Dexrazoxane does not protect against doxorubicin-induced damage in young rats
2003
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
2012 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
2008 Standout
Intermittent fasting prevents the progression of type I diabetic nephropathy in rats and changes the expression of Sir2 and p53
2007
Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis
2002
Chronic angiotensin (17) injection accelerates STZ-induced diabetic renal injury1
2008
Relocalization of Cathepsin D and Cytochrome c Early in Apoptosis Revealed by Immunoelectron Microscopy
2001
Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for nonproteolytic activation of prorenin
2004
Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptor
2011
Doxorubicin Cardiotoxicity and the Control of Iron Metabolism: Quinone-Dependent and Independent Mechanisms
2004
Carnosine Prevents Apoptosis of Glomerular Cells and Podocyte Loss in STZ Diabetic Rats
2011
Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy
2008
STRESS signaling pathways that modulate cardiac myocyte apoptosis
2004
Mitochondrial creatine kinase in human health and disease
2005
Mitochondrial Ca<sup>2+</sup> Signaling and Cardiac Apoptosis
2001
Biodegradable luminescent porous silicon nanoparticles for in vivo applications
2009 Standout
Dexrazoxane (ICRF-187) Protects Cardiac Myocytes Against Doxorubicin by Preventing Damage to Mitochondria
2003
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts
2004 StandoutNature
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
2007
Mitochondria Are a Major Source of Paraquat-induced Reactive Oxygen Species Production in the Brain
2007 Standout
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Endoplasmic reticulum stress: cell life and death decisions
2005 Standout
Role of oxidative stress in cardiovascular diseases
2000
Mitochondria, Oxidants, and Aging
2005 Standout
NADPH oxidase is involved in angiotensin II-induced apoptosis in H9C2 cardiac muscle cells: Effects of apocynin
2005
The ASK1-MAP Kinase Cascades in Mammalian Stress Response
2004
Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo
2006
The renin–angiotensin–aldosterone system, glucose metabolism and diabetes
2005
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
2004 Standout
Four deaths and a funeral: from caspases to alternative mechanisms
2001 Standout
Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Adriamycin-Induced Cardiomyopathy in Hamsters
2002
Protecting the myocardium: A role for the β2 adrenergic receptor in the heart
2004 StandoutNobel
Acute Hemorrhagic Myocardial Necrosis and Sudden Death of Rats Exposed to a Combination of Ephedrine and Caffeine
2004
β-Arrestin 2-Dependent Angiotensin II Type 1A Receptor-Mediated Pathway of Chemotaxis
2005 StandoutNobel
Change in post‐translational modifications of histone H3, heat‐shock protein‐27 and MAP kinase p38 expression by curcumin in streptozotocin‐induced type I diabetic nephropathy
2008
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Renal expression of angiotensin receptors in long-term diabetes and the effects of angiotensin type 1 receptor blockade
2002
Myofibroblast and Endothelial Cell Proliferation during Murine Myocardial Infarct Repair
2003
Potentiation of Doxorubicin Cardiotoxicity by Iron Loading in a Rodent Model
2007
Multiple Interference of Anthracyclines with Mitochondrial Creatine Kinases: Preferential Damage of the Cardiac Isoenzyme and Its Implications for Drug Cardiotoxicity
2002
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Myocarditis
2000 Standout
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Multiple Metabolic Hits Converge on CD36 as Novel Mediator of Tubular Epithelial Apoptosis in Diabetic Nephropathy
2005
Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
2008 Standout
In vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells: The magnetic bio-nanoparticles as drug carriers
2007
Potential protective role of angiotensin‐converting enzyme inhibitors captopril and enalapril against adriamycin‐induced acute cardiac and hepatic toxicity in rats
2001
Structure and function of “metalloantibiotics”
2003
Cardioprotection by chronic estrogen or superoxide dismutase mimetic treatment in the aged female rat
2004
Reactive oxygen species, cellular redox systems, and apoptosis
2010 Standout
Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease
1999
Interactions between doxorubicin and the human iron regulatory system
2003
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
2007 Standout
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Preservation of Fertility in Patients with Cancer
2009 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Redox regulation of cardiac calcium channels and transporters
2006
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Cerium oxide nanoparticles attenuate monocrotaline induced right ventricular hypertrophy following pulmonary arterial hypertension
2014
Overexpression of Angiotensinogen Increases Tubular Apoptosis in Diabetes
2007
Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression
2008
Reactive Oxygen Species-Induced Activation of the MAP Kinase Signaling Pathways
2006
Physiology and Pathophysiology of Carnosine
2013 Standout
Can Angiotensin II Type 2 Receptors Have Deleterious Effects in Cardiovascular Disease?
2004
Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy
2009
Endothelial Nitric Oxide Synthase in Vascular Disease
2006 Standout
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
1995 Standout
Apoptosis: A Review of Programmed Cell Death
2007 Standout
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience
2002 Standout
L‐carnitine prevents doxorubicin‐induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation
1999
Caspase-1, but Not Caspase-3, Promotes Diabetic Nephropathy
2016
Doxorubicin-Dependent Reduction of Ferrylmyoglobin and Inhibition of Lipid Peroxidation: Implications for Cardiotoxicity of Anticancer Anthracyclines
2002
Role of angiotensin II in ischemia/reperfusion‐induced leukocyte‐endothelium interactions in the colon
2004
Doxorubicin Metabolism and Toxicity in Human Myocardium: Role of Cytoplasmic Deglycosidation and Carbonyl Reduction
2000
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Diabetic Cardiomyopathy
2018 Standout
From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines
2004
Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio.
2002
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Diminished molecular response to doxorubicin and loss of cardioprotective effect of dexrazoxane inEgr-1deficient female mice
2001
Pathological Ventricular Remodeling
2013
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Activation of nuclear factor-κB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide
2002
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Mechanisms of Diabetic Complications
2013 Standout
Cellular and Molecular Dissection of Reperfusion Injury
2000 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Oxidative Stress by Monoamine Oxidase Mediates Receptor-Independent Cardiomyocyte Apoptosis by Serotonin and Postischemic Myocardial Injury
2005
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy
2003
Role of iron in anthracycline cardiotoxicity: new tunes for an old song?
1999
Myocardial AKT: The Omnipresent Nexus
2011
Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice
2007
Works of Dinender Kumar being referenced
Apoptosis in Adriamycin Cardiomyopathy and Its Modulation by Probucol
2001
Oxidative Stress and Apoptosis in Heart Dysfunction
2002
Evidence of apoptosis in human diabetic kidney
2004
Tubular and Interstitial Cell Apoptosis in the Streptozotocin-Diabetic Rat Kidney
2004
Adriamycin-induced heart failure: mechanisms and modulation
2000
Vascular remodeling during healing after myocardial infarction in the dog model
2002
Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat
2000
Apoptosis and oxidants in the heart
2003
Regional Differences in Non-enzymatic Antioxidants in the Heart Under Control and Oxidative Stress Conditions
1999
Apoptosis in Isolated Adult Cardiomyocytes Exposed to Adriamycina
1999
AT1and AT2receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts
2002
Adriamycin cardiomyopathy: pathophysiology and prevention
1997
Increased AT(2)R protein expression but not increased apoptosis during cardioprotection induced by AT(1)R blockade.
2002